AXIM (AXIM Biotechnologies) Days Payable: 0.00 (As of Jun. 2025)

What is AXIM Biotechnologies Days Payable?

AXIM Biotechnologies AXIM -16.00% Days Payable is 0.00 as of Jun. 2025. The stock has 7 warning signs investors should review. Among 708 Biotechnology companies, AXIM Biotechnologies ranks worse than 141242.8% on this metric.

AXIM Biotechnologies's average Accounts Payable for the three months ended in Jun. 2025 was $1.86 Mil. AXIM Biotechnologies's Cost of Goods Sold for the three months ended in Jun. 2025 was $0.00 Mil.

The historical rank and industry rank for AXIM Biotechnologies's Days Payable or its related term are showing as below:

During the past 13 years, AXIM Biotechnologies's highest Days Payable was 119068.21. The lowest was 859.17. And the median was 3577.85.

AXIM's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

AXIM Biotechnologies's Days Payable stayed the same from Mar. 2024 (0.00) to Jun. 2025 (0.00). stayed the same

AXIM Biotechnologies Days Payable Related Terms

AXIM Biotechnologies Days Payable Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Days Payable Chart

AXIM Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

0.00

119,068.21

AXIM Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25
Days Payable	Get a 7-Day Free Trial															0.00	150,516.88	0.00	0.00	0.00

AXIM vs HEPA, SCNI, BZYR: Days Payable Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AXIM Biotechnologies Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Days Payable distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Days Payable falls into.

Save Embed

AXIM Biotechnologies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AXIM Biotechnologies's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (2.781	+	1.786)	/	2 )	/	0.007	*	365
=	2.2835					/	0.007	*	365
=	119,068.21

AXIM Biotechnologies's Days Payable for the quarter that ended in Jun. 2025 is calculated as:

	Days Payable (Q: Jun. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2025 )	+	Accounts Payable (Q: Jun. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2025 )	*	Days in Period
=	( (1.928	+	1.796)	/	2 )	/	0	*	365 / 4
=	1.862					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

AXIM Biotechnologies (AXIM) has a Days Payable of 0.00 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AXIM Biotechnologies and its competitors. Over the past decade, AXIM Biotechnologies' Days Payable has ranged from 859.17 to 119,068.21. According to the industry distribution chart, AXIM Biotechnologies ranks #999999 out of 708 companies in the Biotechnology industry.

Is AXIM Biotechnologies' Days Payable too high?

AXIM Biotechnologies' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 859.17 to a high of 119,068.21. Based on the distribution chart, AXIM Biotechnologies ranks #999999 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.

How does AXIM Biotechnologies' Days Payable compare to HEPA and SCNI?

According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #999999 out of 708 companies for Days Payable. This places AXIM Biotechnologies in the lower half of its industry. The industry median Days Payable is 113.56. Historically, AXIM Biotechnologies' own Days Payable has ranged from 859.17 to 119,068.21 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AXIM Biotechnologies and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AXIM Biotechnologies stock overvalued right now?

AXIM Biotechnologies (AXIM) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Days Payable is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Industry Healthcare Biotechnology

Comparable Companies HEPA SCNI BZYR SLXN CLSDQ ZVSA ADAPY BPTH PKTX VRAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121

Website https://www.aximbiotech.com

AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.